Cymra Life Sciences
PrivateMomentum
Top 50%
of companies Caplight tracks
Company Overview
Cymra Life Sciences operates in Healthcare & Life Sciences and is based in Sydney. It was founded in 2017.
Cymra Life Sciences is a biotechnology company that cultivates and manufactures organic medical cannabis products for the treatment of chronic pain.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Pharma Supply Chain
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cymra Life Sciences Comparables
Compare Cymra Life Sciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tasmanian Botanics | 87% | |
| Medcan Australia | 87% | |
| Australian Natural Therapeutics Group | 86% |
For institutional investors. Book with your work email.
Cymra Life Sciences Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 44% MoM, reaching 2.9K.
- May 11, 2026
Monthly visitors grew 350% MoM, reaching 2.4K.
For institutional investors. Book with your work email.
Cymra Life Sciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cymra Life Sciences's valuation, stock price, and market status.
Is Cymra Life Sciences a public or private company?
Cymra Life Sciences is a private company.
What is the current stock price of Cymra Life Sciences?
Cymra Life Sciences is a private company, so its shares have no public market price. Caplight tracks Cymra Life Sciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cymra Life Sciences worth (valuation)?
Valuation information for Cymra Life Sciences is not publicly available.
Can I buy Cymra Life Sciences stock?
Cymra Life Sciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cymra Life Sciences's last funding round?
Funding round information for Cymra Life Sciences is not publicly available.
Who are the main investors in Cymra Life Sciences?
Investor information for Cymra Life Sciences is not publicly disclosed.
Will Cymra Life Sciences IPO soon?
No public IPO plans have been announced for Cymra Life Sciences.
How can I track Cymra Life Sciences secondary market activity?
Caplight tracks bids, offers, and trades in Cymra Life Sciences's shares on secondary markets.